CMC and clinical solutions for making life science easier
CMC and clinical solutions for making life science easier
  • Home
  • Blog
  • Case studies

Case studies

1, Strategic Collaboration for a Recombinant Protein Platform

Role: Business Development

Challenge:

Navigating the complex deal structure and negotiation process to establish a long-term collaboration between a UK-based biotech company and CDMO firms in the US.

Action:

  • Led business development efforts, managing the full BD cycle from prospecting to deal closure.
  • Established strong partnerships with biotech companies in the UK and CDMO firms in the US, facilitating seamless collaboration and regulatory alignment.

Results:

  • Secured long-term collaboration agreements between UK biotech companies and US-based CDMO firms.

2. Strategic Collaboration for CAR-T Therapy

Role: Business Development

Challenge:

Facilitating market entry into China for an advanced cell therapy solution while demonstrating its value to potential clients.

Action:

  • Developed and executed market entry strategies for advanced therapies.
  • Identified key opinion leaders (KOLs) in cell therapy sector in China, negotiated collaboration strategies, and successfully closed partnership deals.

Results:

  • Secured a long-term collaboration between a Chinese CAR-T biotech company and global firms in the US.
  • Established a CAR-T process development laboratory in China to advance local expertise and innovation.

Testimonials

Chief Operating Officer of the Biotech Company

Chief Operating Officer of the Biotech Company

Chief Operating Officer of the Biotech Company

" I was particularly impressed with how Liang managed the most difficult situations efficiently and professionally. He would always think laterally and never let Bio Immunitas down. He will be an asset to the team he joins. Highly recommended"

Executive Editor of Life Science Community

Chief Operating Officer of the Biotech Company

Chief Operating Officer of the Biotech Company

“I collaborated with Liang on a publishing project and found him to be professional, attentive, and tuned into what our specific audience is looking for. He had a strong grasp of the subject matter, which was clinical supply manufacturing for next-generation cell therapy, and he organized his ideas clearly to communicate the issues with our readers. I look forward to working with him in the future.”.

Chief Medical Officer of the CRO company

Chief Operating Officer of the Biotech Company

Chief Medical Officer of the CRO company

“Our team has been working with Mr Liang Li since 2020 as he has been a most effective contact point for research in EU area of the company drug development planning.” 

Later on, in 2023-2024 yrs Mr Liang Li was leading BD in OMC and his energy and vision had implemented tremendous efforts on his new company endeavor. Mr Liang Li has always been scheduled to the hot topics of the company agenda and working without spending his time on these topics. He has shown to us 2”.

Copyright © 2024 CMClinicalsolution- All Rights Reserved.

  • Privacy Policy

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept